Jury Mulls Arguments In Latest Vioxx Trial

Law360, New York (December 13, 2006, 12:00 AM EST) -- A New Orleans jury in the twelfth civil trial over Merck & Co.’s ill-fated Vioxx headed into deliberations on Wednesday after lawyers representing the pharmaceutical giant called into question the credibility of a Tennessee man who had a heart attack in 2003 after taking the painkiller.

Merck attorneys said in closing arguments that 50-year-old Anthony Wayne Dedrick, who blames his health troubles on Vioxx, has a history of dishonesty, including five worthless-check convictions and allegations that he lied under oath at a disability hearing, Dow Jones...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.